A carregar...
Deep molecular responses for treatment‐free remission in chronic myeloid leukemia
Several clinical trials have demonstrated that some patients with chronic myeloid leukemia in chronic phase (CML‐CP) who achieve sustained deep molecular responses on tyrosine kinase inhibitor (TKI) therapy can safely suspend therapy and attempt treatment‐free remission (TFR). Many TFR studies to da...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5055167/ https://ncbi.nlm.nih.gov/pubmed/27367039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.801 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|